CAMBRIDGE, Mass.--(BUSINESS WIRE)--AXONIS Therapeutics, Inc., an emerging biotechnology company advancing breakthrough research to develop therapies for neurological disorders, today announced it has ...
This describes Retraining and Control Therapy, or ReACT, the reason for being of UAB’s latest startup, ReACT FND Health. The company’s chief scientific officer and founder is clinical psychologist ...
Tiny immune cells called microglia protect the central nervous system (CNS) in a multitude of ways: They provide innate ...
Long Covid — the name adopted for cases of prolonged symptoms after an acute bout of Covid-19 — is an umbrella diagnosis covering a broad range of clinical presentations and abnormal biological ...
The number of people living with neurological disorders, such as Alzheimer’s disease, epilepsy, multiple sclerosis and Parkinson’s disease, has increased as the population has aged. At the same time, ...
Neurological disorders are becoming more common worldwide, a new study has found. The number of people living and dying with such conditions as Alzheimer's disease, other dementias, meningitis, and ...
12don MSN
One in two people in the US is affected by a neurological disease or disorder, analysis shows
One in two people in the United States, just over half of the population, is affected by a neurological disease or disorder, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback